10-Q: NewHydrogen Q1 2026 Financial Results Overview

Sentiment:

Quarterly Report


NewHydrogen reports a net loss of $822,996 for Q1 2026 as it continues development of its ThermoLoop green hydrogen technology.

Capital raiseThe company maintains an equity financing agreement with GHS Investments LLC to provide up to $3,000,000 in capital.Management explicitly states the need for additional capital resources during 2026 to continue operations.

Summary

  • Reported a net loss of $822,996 for the three months ended March 31, 2026, compared to a loss of $476,094 in the same period of 2025.
  • Operating expenses increased to $822,701, driven primarily by higher research and development costs ($331,513) and general and administrative expenses ($396,798).
  • Cash balance decreased to $714,341 as of March 31, 2026, from $1,436,928 at the end of 2025.
  • The company remains in the development stage with no revenue generated during the quarter.
  • Working capital is reported at $751,663, with management noting sufficient funds for approximately four months of operations.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a high-risk report due to the substantial doubt regarding the company's ability to continue as a going concern and the significant increase in net losses.

Positives

  • Continued progress on the ThermoLoop technology development program at UC Santa Barbara.
  • Maintained effective disclosure controls and procedures as of March 31, 2026.
  • Successful utilization of the equity financing agreement to support ongoing research activities.

Negatives

  • Net loss widened significantly to $822,996 compared to $476,094 in the prior year period.
  • Cash reserves declined by over 50% during the quarter.
  • Accumulated deficit reached $181,612,486.
  • Continued reliance on external financing to fund operations with no revenue generation.

Risks

  • Substantial doubt exists regarding the company's ability to continue as a going concern.
  • Dependence on the ability to secure additional equity or debt financing to sustain operations.
  • Potential for significant dilution to existing shareholders through future equity raises.
  • Risks associated with the development of unproven thermochemical water splitting technology.
  • Market volatility and economic factors impacting the ability to raise capital on favorable terms.

Future Outlook

Management expects to maintain the existing ThermoLoop technology development program at UCSB using current cash balances, which are estimated to be sufficient for the next four months. Increased expenses are anticipated in early 2027 as the company ramps up prototyping efforts.

Management Comments

  • Management believes that funding from existing and prospective new investors and future revenue will provide the additional cash needed to meet obligations.
  • The company is significantly dependent upon its ability to secure additional equity and/or debt financing.

Industry Context

StockSavvy.ai notes that NewHydrogen operates in the highly speculative green hydrogen technology sector, where companies are currently facing intense pressure to demonstrate commercial viability while managing high cash burn rates in a challenging capital-raising environment.

Comparison to Industry Standards

  • The company's pre-revenue status is common for early-stage clean-tech firms but places it at a disadvantage compared to established hydrogen players like Plug Power or Bloom Energy.
  • The reliance on equity financing agreements is a standard, albeit dilutive, survival mechanism for small-cap development-stage companies in the energy sector.

Legal Proceedings

  • None reported.

Stakeholder Impact

  • Shareholders face potential dilution from future capital raises.
  • Creditors and suppliers remain exposed to the company's going concern risk.

Next Steps

  • Continue ThermoLoop technology development program at UC Santa Barbara.
  • Seek additional equity or debt financing to support operations beyond the next four months.
  • Prepare for potential ramp-up of prototyping efforts in early 2027.

Key Dates

DateDescription
2026-01-01Beginning of the quarterly reporting period.
2026-03-31End of the quarterly reporting period.
2026-05-15Filing date of the Form 10-Q.

Recommendation

hold

The company is in a high-risk development phase with no revenue and significant liquidity concerns. Investors should hold until there is clear evidence of commercial viability or a successful, non-dilutive capital infusion.

Keywords

NewHydrogen, Green Hydrogen, ThermoLoop, Clean Energy, Thermochemical Water Splitting, 10-Q

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.